查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1698157

生物製药物流市场－全球产业规模、份额、趋势、机会和预测（按服务、营运类型、区域和竞争细分，2020-2030 年）

Bio-Pharma Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Type of Operation Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球生物製药物流市场价值为 803.6 亿美元，预计在预测期内将实现强劲成长，到 2030 年的复合年增长率为 7.16%。全球生物製药物流市场是一个充满活力且快速发展的行业，在製药和生物技术行业中发挥关键作用。它涵盖生物製药产品（包括疫苗、药品、生物製剂和临床试验材料）的储存、运输和分销的规划、执行和管理。该市场受到几个关键因素的推动，包括对生物製药产品的需求不断增加、製药供应链的全球化以及对专门的温控和时间敏感的物流解决方案的需求，以保持敏感生物製药产品的完整性。

市场概览
预测期 2026-2030
2024年市场规模 803.6亿美元
2030年市场规模 1207.1亿美元
2025-2030 年复合年增长率 7.16%
成长最快的领域 冷链
最大的市场 北美洲

全球生物製药物流市场的主要驱动力之一是生物製药产品需求的不断增长。随着生物技术和製药研究的进步导致药物更加复杂和个人化，对可靠、高效的物流服务来运输和储存这些产品的需求至关重要。新冠疫情凸显了强大供应链的重要性，以确保在全球范围内及时交付疫苗和治疗药物。

关键市场驱动因素

生物製药产品需求不断成长

主要市场挑战

温度控制和监测

主要市场趋势

温控物流

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球生物製药物流市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按服务（运输、仓储及配送、加值服务）
    • 依操作类型（冷链、非冷链）
    • 按地区
    • 按公司分类（2024）
  • 市场地图
    • 按服务
    • 按营运类型
    • 按地区

第五章：亚太生物製药物流市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按服务
    • 按营运类型
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第六章：欧洲生物製药物流市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 西班牙
    • 义大利
    • 英国

第七章：北美生物製药物流市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 墨西哥
    • 加拿大

第八章：南美洲生物製药物流市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第九章：中东和非洲生物製药物流市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 埃及

第十章：市场动态

  • 驱动程式
  • 挑战

第 11 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 12 章：全球生物製药物流市场：SWOT 分析

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Kerry Logistics Network Limited
  • Deutsche Post AG
  • DHL Group
  • Kuehne + Nagel International AG
  • UPS (Marken) Inc.
  • DB Schenker
  • FedEx Corp.
  • Nippon Express Co Ltd
  • World Courier Inc.
  • SF Express

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 20292

Global Bio-Pharma Logistics Market was valued at USD 80.36 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 7.16% through 2030. The Global Bio-Pharma Logistics Market is a dynamic and rapidly evolving sector that plays a critical role in the pharmaceutical and biotechnology industries. It encompasses the planning, execution, and management of the storage, transportation, and distribution of biopharmaceutical products, including vaccines, pharmaceuticals, biologics, and clinical trial materials. This market is driven by several key factors, including the increasing demand for biopharmaceutical products, the globalization of the pharmaceutical supply chain, and the need for specialized temperature-controlled and time-sensitive logistics solutions to maintain the integrity of sensitive biopharmaceutical products.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 80.36 Billion
Market Size 2030USD 120.71 Billion
CAGR 2025-20307.16%
Fastest Growing SegmentCold Chain
Largest MarketNorth America

One of the major drivers of the Global Bio-Pharma Logistics Market is the growing demand for biopharmaceutical products. As advancements in biotechnology and pharmaceutical research lead to the development of more complex and personalized medicines, the need for reliable and efficient logistics services to transport and store these products is paramount. COVID-19 pandemic has underscored the importance of a robust supply chain to ensure the timely delivery of vaccines and therapeutic drugs on a global scale.

Key Market Drivers

Increasing Demand for Biopharmaceutical Products

The increasing demand for biopharmaceutical products is a pivotal factor driving the growth of the Global Bio-Pharma Logistics Market. Biopharmaceuticals, which include vaccines, monoclonal antibodies, gene therapies, and other advanced therapeutic modalities, have gained significant traction in recent years due to their remarkable efficacy in treating a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. This surge in biopharmaceutical development has catalyzed a corresponding need for efficient and specialized logistics solutions to ensure that these products are manufactured, transported, and distributed seamlessly across the globe. For instance, according to data from the Medical Logistics Branch of the China Federation of Things, the cold vaccine chain market in 2021 was valued at approximately CNY 48.14 billion (USD 7 billion), reflecting a year-on-year growth of 23.3%. In recent years, China has heavily invested in enhancing the development of cold vaccine chains and nationwide traceability systems.

Key Market Challenges

Temperature Control and Monitoring

Temperature control and monitoring pose a significant challenge to the Global Bio-Pharma Logistics Market. Biopharmaceutical products, including vaccines, biologics, gene therapies, and other advanced therapeutics, are highly sensitive to temperature fluctuations. Ensuring that these products are transported and stored under precise temperature conditions is essential to maintain their integrity, safety, and efficacy. The inability to address this challenge effectively can have far-reaching consequences for both the pharmaceutical industry and patient health.

One of the primary issues facing the bio-pharma logistics sector is the need for maintaining a consistent temperature throughout the entire supply chain. These products often require stringent temperature control, with variations outside the specified range potentially rendering them ineffective or even dangerous to patients. Achieving this level of temperature control presents several challenges.

The transportation of biopharmaceuticals involves a complex and multifaceted network of providers, including manufacturers, carriers, distribution centers, and healthcare facilities. Each of these entities must adhere to strict temperature requirements to ensure product quality. Any lapse in temperature control at any point along the supply chain can jeopardize the safety and efficacy of the products.

Key Market Trends

Temperature-Controlled Logistics

Temperature-controlled logistics plays a pivotal role in boosting the Global Bio-Pharma Logistics Market. This key trend addresses one of the most critical challenges facing the pharmaceutical and biotechnology sectors: the need to ensure the safe and effective transportation of temperature-sensitive biopharmaceutical products. As the demand for vaccines, biologics, gene therapies, and other advanced therapeutic modalities continues to grow, the necessity for maintaining precise temperature conditions throughout the supply chain has never been more significant. For instance, India ranks among the top 12 biotechnology destinations globally. In 2021, the country witnessed a significant surge in biotech startup registrations, with approximately 1,128 new startups registered-the highest in a single year since 2015. By the end of 2021, the total number of biotechnology startups reached 5,365, with projections suggesting this figure will rise to 10,000 by 2024. India is home to 665 FDA-approved plants in the U.S., accounts for 44% of global abbreviated new drug applications (ANDA), and has over 1,400 manufacturing plants meeting WHO standards. Also, India is the world's third-largest producer of the recombinant Hepatitis B vaccine.

Key Market Players

  • Kerry Logistics Network Limited
  • Deutsche Post AG
  • DHL Group
  • Kuehne + Nagel International AG
  • UPS (Marken) Inc.
  • DB Schenker
  • FedEx Corp
  • Nippon Express Co Ltd
  • World Courier Inc
  • SF Express

Report Scope:

In this report, the Global Bio-Pharma Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Pharma Logistics Market, By Service:

  • Transportation
  • Warehousing and Distribution
  • Value Added Services

Bio-Pharma Logistics Market, By Type of Operation:

  • Cold Chain
  • Non-cold Chain

Bio-Pharma Logistics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Pharma Logistics Market.

Available Customizations:

Global Bio-Pharma Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bio-Pharma Logistics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Service (Transportation, Warehousing and Distribution, Value Added Services)
    • 4.2.2. By Type of Operation (Cold Chain, Non-cold Chain)
    • 4.2.3. By Region
    • 4.2.4. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Service
    • 4.3.2. By Type of Operation
    • 4.3.3. By Region

5. Asia Pacific Bio-Pharma Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service
    • 5.2.2. By Type of Operation
    • 5.2.3. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Bio-Pharma Logistics Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Service
        • 5.3.1.2.2. By Type of Operation
    • 5.3.2. India Bio-Pharma Logistics Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Service
        • 5.3.2.2.2. By Type of Operation
    • 5.3.3. Australia Bio-Pharma Logistics Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Service
        • 5.3.3.2.2. By Type of Operation
    • 5.3.4. Japan Bio-Pharma Logistics Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Service
        • 5.3.4.2.2. By Type of Operation
    • 5.3.5. South Korea Bio-Pharma Logistics Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Service
        • 5.3.5.2.2. By Type of Operation

6. Europe Bio-Pharma Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Type of Operation
    • 6.2.3. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Bio-Pharma Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Type of Operation
    • 6.3.2. Germany Bio-Pharma Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Type of Operation
    • 6.3.3. Spain Bio-Pharma Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Type of Operation
    • 6.3.4. Italy Bio-Pharma Logistics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Service
        • 6.3.4.2.2. By Type of Operation
    • 6.3.5. United Kingdom Bio-Pharma Logistics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Service
        • 6.3.5.2.2. By Type of Operation

7. North America Bio-Pharma Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Type of Operation
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Bio-Pharma Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Type of Operation
    • 7.3.2. Mexico Bio-Pharma Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Type of Operation
    • 7.3.3. Canada Bio-Pharma Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Type of Operation

8. South America Bio-Pharma Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Type of Operation
    • 8.2.3. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Bio-Pharma Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Type of Operation
    • 8.3.2. Argentina Bio-Pharma Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Type of Operation
    • 8.3.3. Colombia Bio-Pharma Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Type of Operation

9. Middle East and Africa Bio-Pharma Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Type of Operation
    • 9.2.3. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Bio-Pharma Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Type of Operation
    • 9.3.2. Saudi Arabia Bio-Pharma Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Type of Operation
    • 9.3.3. UAE Bio-Pharma Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Type of Operation
    • 9.3.4. Egypt Bio-Pharma Logistics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Service
        • 9.3.4.2.2. By Type of Operation

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Bio-Pharma Logistics Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Kerry Logistics Network Limited
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Deutsche Post AG
  • 14.3. DHL Group
  • 14.4. Kuehne + Nagel International AG
  • 14.5. UPS (Marken) Inc.
  • 14.6. DB Schenker
  • 14.7. FedEx Corp.
  • 14.8. Nippon Express Co Ltd
  • 14.9. World Courier Inc.
  • 14.10.SF Express

15. Strategic Recommendations

16. About Us & Disclaimer